We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$337M
AUM Growth
-$196M
Cap. Flow
-$116M
Cap. Flow %
-34.61%
Top 10 Hldgs %
96.85%
Holding
22
New
2
Increased
5
Reduced
7
Closed
3

Top Buys

Rank Stock Value
1
AGEN
Agenus
AGEN
+$8.28M
2
QDEL icon
QuidelOrtho
QDEL
+$3.96M
3
ATRS
Antares Pharma, Inc.
ATRS
+$1.83M
4
YMAB
Y-mAbs Therapeutics
YMAB
+$732K
5
PACB icon
Pacific Biosciences
PACB
+$449K

Top Sells

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$56.3M
2
DERM
Dermira, Inc.
DERM
+$38.3M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$2.4M
4
COR icon
Cencora
COR
+$2.13M
5
AXDX
Accelerate Diagnostics
AXDX
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 98.77%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$177M 52.48%
1,805,983
+48,995
+3% +$3.96M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$63.7M 18.91%
1,870,743
-52,547
-3% -$2.4M
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
$34.2M 10.15%
410,229
-11,086
-3% -$1.56M
AGEN
4
Agenus
AGEN
$275M
$13.1M 3.9%
273,136
+131,897
+93% +$8.28M
SLNO
5
DELISTED
Soleno Therapeutics
SLNO
$9.21M 2.74%
258,042
– –
VRML
6
DELISTED
Vermillion, Inc.
VRML
$8.18M 2.43%
9,825,289
– –
AMRN
7
Amarin Corp
AMRN
$293M
$7.34M 2.18%
91,782
-169,518
-65% -$56.3M
OPK icon
8
Opko Health
OPK
$1.23B
$5.99M 1.78%
4,473,076
+100,000
+2% +$157K
QDEL icon
9
CALL
QuidelOrtho
QDEL
$1.14B
$3.88M 1.15%
157,400
-90,300
-36% -$7.3M
PACB icon
10
Pacific Biosciences
PACB
$432M
$3.73M 1.11%
1,220,359
+109,693
+10% +$449K
ATRS
11
DELISTED
Antares Pharma, Inc.
ATRS
$2.9M 0.86%
1,227,114
+538,877
+78% +$1.83M
MOTS
12
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$2.56M 0.76%
12,689
– –
BIOL
13
DELISTED
Biolase, Inc.
BIOL
$1.94M 0.58%
2,069
– –
BIIB icon
14
Biogen
BIIB
$30.4B
$1.54M 0.46%
4,868
– –
CFRX
15
DELISTED
ContraFect Corporation
CFRX
$742K 0.22%
1,611
-267
-14% -$182K
YMAB
16
DELISTED
Y-mAbs Therapeutics
YMAB
$658K 0.2%
+25,212
New +$732K
BHVN
17
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$218K 0.06%
+100,000
New +$4.57M
AXDX
18
CALL
DELISTED
Accelerate Diagnostics
AXDX
$55K 0.02%
38,840
-9,510
-20% -$1.34M
AMRN
19
CALL
Amarin Corp
AMRN
$293M
$2K ﹤0.01%
17,550
-80,430
-82% -$26.7M
COR icon
20
Cencora
COR
$62.2B
– –
-25,000
Closed -$2.13M
DB icon
21
Deutsche Bank
DB
$67.6B
– –
-25,000
Closed -$195K
DERM
22
DELISTED
Dermira, Inc.
DERM
– –
-2,528,311
Closed -$38.3M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2020 Portfolio in Review

As of Q1 2020, Oracle Investment Management held 22 positions worth $337M, down 37% from $533M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Oracle Investment Management withdrew a net $116M in Q1 2020, closing 3 positions and reducing 7 holdings. Its most notable exit was Dermira, Inc., an estimated $38.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 90% a quarter earlier, followed by Financials.

Against the trend, Oracle Investment Management opened a new position in Y-mAbs Therapeutics worth $658K.

  • Oracle Investment Management's largest Q1 2020 buy was Y-mAbs Therapeutics: 25,212 shares worth $658K.
  • Oracle Investment Management added most to Agenus in Q1 2020, an estimated $8.28M increase.
  • Oracle Investment Management's biggest Q1 2020 reduction was Amarin Corp, cutting an estimated $56.3M.
  • Oracle Investment Management fully exited Dermira, Inc. in Q1 2020, selling an estimated $38.3M.
  • Oracle Investment Management's ten largest holdings make up 97% of its $337M portfolio in Q1 2020.
  • Oracle Investment Management opened 2 new positions and closed 3 in Q1 2020.
  • Oracle Investment Management's portfolio value fell 37% quarter-over-quarter to $337M.

Based on Oracle Investment Management's 13F filing for Q1 2020, filed 15 May 2020.